Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
24 11 2020
Historique:
received: 07 05 2020
revised: 21 09 2020
accepted: 04 11 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 17 12 2021
Statut: ppublish

Résumé

Soluble envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit neutralizing responses against HIV-1 strains closely related to the immunizing trimer. However, to date such stabilization has succeeded with only a limited number of HIV-1 strains. To address this issue, here we develop ADROITrimer, an automated procedure involving structure-based stabilization and consensus repair, and generate "RnS-DS-SOSIP"-stabilized Envs from 180 diverse Env sequences. The vast majority of these RnS-DS-SOSIP Envs fold into prefusion-closed conformations as judged by antigenic analysis and size exclusion chromatography. Additionally, representative strains from clades AE, B, and C are stabilized in prefusion-closed conformations as shown by negative-stain electron microscopy, and the crystal structure of a clade A strain MI369.A5 Env trimer provides 3.5 Å resolution detail into stabilization and repair mutations. The automated procedure reported herein that yields well-behaved, soluble, prefusion-closed Env trimers from a majority of HIV-1 strains could have substantial impact on the development of an HIV-1 vaccine.

Identifiants

pubmed: 33238130
pii: S2211-1247(20)31421-2
doi: 10.1016/j.celrep.2020.108432
pmc: PMC7714614
mid: NIHMS1649698
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
HIV Antibodies 0
env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

108432

Subventions

Organisme : Intramural NIH HHS
ID : ZIA AI005024
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIC AI005113
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIC AI005114
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Interests These studies were funded in part by Janssen Vaccines and Prevention. L.R., S.B., J.J., and J.P.M.L. are employees of Janssen. L.R. and J.P.M.L. are inventors on an international patent application describing trimer stabilizing HIV envelope protein mutations.

Références

Curr Chem Genomics. 2008 Feb 25;1:2-10
pubmed: 20161822
Immunity. 2018 Mar 20;48(3):500-513.e6
pubmed: 29548671
J Virol. 2002 Sep;76(17):8875-89
pubmed: 12163607
Nat Struct Mol Biol. 2010 Aug;17(8):955-61
pubmed: 20622876
PLoS Pathog. 2013 Sep;9(9):e1003618
pubmed: 24068931
J Virol. 2006 Jan;80(2):835-44
pubmed: 16378985
PLoS Pathog. 2016 Sep 14;12(9):e1005864
pubmed: 27627672
Nat Commun. 2017 Nov 21;8(1):1655
pubmed: 29162799
Nat Commun. 2019 Feb 13;10(1):721
pubmed: 30760721
Immunity. 2015 Dec 15;43(6):1053-63
pubmed: 26682982
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18256-61
pubmed: 24145402
Nat Commun. 2016 Jun 28;7:12040
pubmed: 27349805
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11947-52
pubmed: 26372963
J Virol. 2004 Mar;78(5):2394-404
pubmed: 14963135
J Virol. 2014 Sep 1;88(17):9590-604
pubmed: 24920800
Immunity. 2014 May 15;40(5):657-68
pubmed: 24768347
Cell Rep. 2017 Dec 5;21(10):2992-3002
pubmed: 29212041
PLoS Pathog. 2009 May;5(5):e1000445
pubmed: 19478876
Biochemistry. 2013 Sep 10;52(36):6249-57
pubmed: 23944979
Nature. 2014 Oct 23;514(7523):455-61
pubmed: 25296255
Sci Adv. 2018 Nov 21;4(11):eaau6769
pubmed: 30474059
Science. 2013 Dec 20;342(6165):1484-90
pubmed: 24179160
Science. 1998 Jun 19;280(5371):1884-8
pubmed: 9632381
Immunity. 2017 May 16;46(5):792-803.e3
pubmed: 28514686
Cell Rep. 2018 Apr 10;23(2):584-595
pubmed: 29642014
Cell Rep. 2017 Aug 22;20(8):1805-1817
pubmed: 28834745
Immunol Rev. 2017 Jan;275(1):161-182
pubmed: 28133806
J Virol. 2016 Sep 29;90(20):9471-82
pubmed: 27512064
Immunity. 2017 Jun 20;46(6):1073-1088.e6
pubmed: 28636956
J Mol Biol. 2007 May 4;368(3):652-65
pubmed: 17362988
J Virol. 2013 May;87(10):5372-83
pubmed: 23468492
Immunity. 2017 May 16;46(5):804-817.e7
pubmed: 28514687
J Virol. 2000 Jan;74(2):627-43
pubmed: 10623724
Nature. 1998 Jun 18;393(6686):648-59
pubmed: 9641677
Cell Host Microbe. 2019 Jan 9;25(1):59-72.e8
pubmed: 30629920
J Virol. 2015 Oct 14;90(1):76-91
pubmed: 26468542
Vaccine. 2007 May 16;25(20):4085-92
pubmed: 17391815
Science. 2016 May 13;352(6287):828-33
pubmed: 27174988
Nature. 2011 Nov 23;480(7377):336-43
pubmed: 22113616
PLoS Pathog. 2016 Aug 03;12(8):e1005767
pubmed: 27487086
Immunity. 2016 Nov 15;45(5):1108-1121
pubmed: 27851912
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17624-9
pubmed: 25422458
J Virol. 2017 Oct 27;91(22):
pubmed: 28878072
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
Nat Struct Mol Biol. 2015 Jul;22(7):522-31
pubmed: 26098315
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Science. 2013 Dec 20;342(6165):1477-83
pubmed: 24179159
Biotechnol Bioeng. 2018 Apr;115(4):885-899
pubmed: 29150937
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
J Virol. 2015 Dec 30;90(6):2806-17
pubmed: 26719252
Curr Opin HIV AIDS. 2017 May;12(3):229-240
pubmed: 28422787
Immunity. 2016 Sep 20;45(3):483-496
pubmed: 27617678
J Virol. 2017 Apr 28;91(10):
pubmed: 28275193
J Virol. 2015 Dec 30;90(6):2740-55
pubmed: 26719262
Cell Rep. 2017 Feb 28;18(9):2175-2188
pubmed: 28249163
Nat Commun. 2019 Jan 3;10(1):47
pubmed: 30604750
Trends Immunol. 2016 Mar;37(3):221-232
pubmed: 26869204
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8060-5
pubmed: 16690741
Virology. 2015 May;479-480:498-507
pubmed: 25866377
Cell. 2015 Dec 17;163(7):1702-15
pubmed: 26687358
Science. 2010 Aug 13;329(5993):811-7
pubmed: 20616231
Nature. 2011 Sep 22;477(7365):466-70
pubmed: 21849977
Immunol Rev. 2017 Jan;275(1):21-32
pubmed: 28133813
Science. 2009 Nov 20;326(5956):1123-7
pubmed: 19965434
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Science. 2013 Nov 1;342(6158):592-8
pubmed: 24179220
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Reda Rawi (R)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Lucy Rutten (L)

Janssen Vaccines & Prevention, Archimedesweg 4-6, 2333 CN Leiden, the Netherlands.

Yen-Ting Lai (YT)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Adam S Olia (AS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Sven Blokland (S)

Janssen Vaccines & Prevention, Archimedesweg 4-6, 2333 CN Leiden, the Netherlands.

Jarek Juraszek (J)

Janssen Vaccines & Prevention, Archimedesweg 4-6, 2333 CN Leiden, the Netherlands.

Chen-Hsiang Shen (CH)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Yaroslav Tsybovsky (Y)

Electron Microscopy Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21701, USA.

Raffaello Verardi (R)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Yongping Yang (Y)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Baoshan Zhang (B)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Tongqing Zhou (T)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Gwo-Yu Chuang (GY)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: gwo-yu.chuang@nih.gov.

Peter D Kwong (PD)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: pdkwong@nih.gov.

Johannes P M Langedijk (JPM)

Janssen Vaccines & Prevention, Archimedesweg 4-6, 2333 CN Leiden, the Netherlands. Electronic address: hlangedi@its.jnj.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH